Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if used to treat acute asthma attacks, calling it the first major advance for this aspect of the disease in 50 ...

At the time of the attack, the treatment consists of an injection of benralizumab, in a high dose. As reported by the media RTBF, benralizumab is a monoclonal antibody that targets specific white ...

The same biological mechanism also underlies a third of all ... with asthma attacks almost every day. But the benralizumab injection he had in hospital helped stabilise his disease.